Hepatic steatosis is a driving force for NAFLD because increased intracellular TG accumulation induces inflammation, oxidative stress and insulin resistance by generating lipotoxic intermediates, which leads to NASH, fibrosis and cirrhosis [2]. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.